Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

    This grant aims to investigate how incretin mimetics affect cancer risk, focusing on mechanisms rather than short-term outcomes like weight loss, to attract scientific talent for preclinical and patient studies.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

    Study to understand how incretin mimetics affect cancer risk and attract experts to investigate these mechanisms, aiming to differentiate impacts on cancer risk from other health outcomes like weight loss or diabetes.

    HHS-NIH11Due Nov 5, 2026· 7d

    Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)

    Investigating how bariatric surgery affects cancer risk, supporting novel studies, exploring unknown mechanisms with the aim of finding proof of concept.

    HHS-NIH11Due Nov 16, 2026· 18d$275,000

    Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)

    NCI invites studies on how bariatric surgery affects cancer risk to attract researchers focusing on long-term cancer effects, not just weight loss or diabetes outcomes.

    HHS-NIH11Due Nov 5, 2026· 7d$2,500,000

    Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

    Research grant to understand and treat long-term side effects of cancer therapy through mechanistic and clinical studies supporting therapeutic interventions.

    HHS-NIH11Due Nov 5, 2026· 7d

    The Economic Implications of GLP-1 Therapies

    The Economic Implications of GLP-1 Therapies supports researchers through a conference on treatment costs, insurance, and broader economic effects to examine the economic implications of growing GLP-1 use.

    NBERDue Dec 15, 2026